This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorsteinsdottir, U.
Right arrow Articles by Sauvageau, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorsteinsdottir, U.
Right arrow Articles by Sauvageau, G.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2001, p. 224-234, Vol. 21, No. 1
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.1.224-234.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Defining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia

Unnur Thorsteinsdottir,1 Evert Kroon,1 Lori Jerome,1 Francesco Blasi,2 and Guy Sauvageau1,3,4,*

Laboratory of Molecular Genetics of Hemopoietic Stem Cells, Clinical Research Institute of Montréal, Montréal, Québec H2W 1R7,1 Department of Medicine, Université de Montréal, Montréal, Québec H3C 3J7,3 and Division of Hematology, Maisonneuve-Rosemont Hospital, Université de Montréal, Montréal, Québec H1T 2M2,4 Canada, and Molecular Genetics Unit, DIBIT, Universita Vita-Salute San Raffaele, 20132 Milan, Italy2

Received 21 July 2000/Returned for modification 13 September 2000/Accepted 12 October 2000

Complex genetic and biochemical interactions between HOX proteins and members of the TALE (i.e., PBX and MEIS) family have been identified in embryonic development, and some of these interactions also appear to be important for leukemic transformation. We have previously shown that HOXA9 collaborates with MEIS1 in the induction of acute myeloid leukemia (AML). In this report, we demonstrate that HOXB3, which is highly divergent from HOXA9, also genetically interacts with MEIS1, but not with PBX1, in generating AML. In addition, we show that the HOXA9 and HOXB3 genes play key roles in establishing all the main characteristics of the leukemias, while MEIS1 functions only to accelerate the onset of the leukemic transformation. Contrasting the reported functional similarities between PREP1 and MEIS1, such as PBX nuclear retention, we also show that PREP1 overexpression is incapable of accelerating the HOXA9-induced AML, suggesting that MEIS1 function in transformation must entail more than PBX nuclear localization. Collectively, these data demonstrate that MEIS1 is a common leukemic collaborator with two structurally and functionally divergent HOX genes and that, in this collaboration, the HOX gene defines the identity of the leukemia.

* Corresponding author. Mailing address: Institut de Recherches Cliniques de Montréal, 110 Pine Ave. West, Montreal, Quebec, Canada H2W 1R7. Phone: (514) 987-5797. Fax: (514) 987-5718. E-mail: sauvagg{at}ircm.qc.ca.

Molecular and Cellular Biology, January 2001, p. 224-234, Vol. 21, No. 1
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.1.224-234.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Fiskus, W., Wang, Y., Sreekumar, A., Buckley, K. M., Shi, H., Jillella, A., Ustun, C., Rao, R., Fernandez, P., Chen, J., Balusu, R., Koul, S., Atadja, P., Marquez, V. E., Bhalla, K. N. (2009). Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood 114: 2733-2743 [Abstract] [Full Text]  
  • Goh, S.-L., Looi, Y., Shen, H., Fang, J., Bodner, C., Houle, M., Ng, A. C.-H., Screaton, R. A., Featherstone, M. (2009). Transcriptional Activation by MEIS1A in Response to Protein Kinase A Signaling Requires the Transducers of Regulated CREB Family of CREB Co-activators. J. Biol. Chem. 284: 18904-18912 [Abstract] [Full Text]  
  • Xiong, L., Catoire, H., Dion, P., Gaspar, C., Lafreniere, R. G., Girard, S. L., Levchenko, A., Riviere, J.-B., Fiori, L., St-Onge, J., Bachand, I., Thibodeau, P., Allen, R., Earley, C., Turecki, G., Montplaisir, J., Rouleau, G. A. (2009). MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum Mol Genet 18: 1065-1074 [Abstract] [Full Text]  
  • Roth, J. J., Crist, R. C., Buchberg, A. M. (2009). Might as well face it: MLL's addicted to HOX. Blood 113: 2372-2373 [Full Text]  
  • Faber, J., Krivtsov, A. V., Stubbs, M. C., Wright, R., Davis, T. N., van den Heuvel-Eibrink, M., Zwaan, C. M., Kung, A. L., Armstrong, S. A. (2009). HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 113: 2375-2385 [Abstract] [Full Text]  
  • Ruedl, C., Khameneh, H. J., Karjalainen, K. (2008). Manipulation of immune system via immortal bone marrow stem cells. Int Immunol 20: 1211-1218 [Abstract] [Full Text]  
  • Rawat, V. P. S., Thoene, S., Naidu, V. M., Arseni, N., Heilmeier, B., Metzeler, K., Petropoulos, K., Deshpande, A., Quintanilla-Martinez, L., Bohlander, S. K., Spiekermann, K., Hiddemann, W., Feuring-Buske, M., Buske, C. (2008). Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia. Blood 111: 309-319 [Abstract] [Full Text]  
  • Caudell, D., Zhang, Z., Chung, Y. J., Aplan, P. D. (2007). Expression of a CALM-AF10 Fusion Gene Leads to Hoxa Cluster Overexpression and Acute Leukemia in Transgenic Mice. Cancer Res. 67: 8022-8031 [Abstract] [Full Text]  
  • Slape, C., Hartung, H., Lin, Y.-W., Bies, J., Wolff, L., Aplan, P. D. (2007). Retroviral Insertional Mutagenesis Identifies Genes that Collaborate with NUP98-HOXD13 during Leukemic Transformation. Cancer Res. 67: 5148-5155 [Abstract] [Full Text]  
  • Fiskus, W., Pranpat, M., Balasis, M., Herger, B., Rao, R., Chinnaiyan, A., Atadja, P., Bhalla, K. (2006). Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Molecular Cancer Therapeutics 5: 3096-3104 [Abstract] [Full Text]  
  • Mamo, A., Krosl, J., Kroon, E., Bijl, J., Thompson, A., Mayotte, N., Girard, S., Bisaillon, R., Beslu, N., Featherstone, M., Sauvageau, G. (2006). Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation. Blood 108: 622-629 [Abstract] [Full Text]  
  • Hess, J. L., Bittner, C. B., Zeisig, D. T., Bach, C., Fuchs, U., Borkhardt, A., Frampton, J., Slany, R. K. (2006). c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood 108: 297-304 [Abstract] [Full Text]  
  • Wang, G. G., Pasillas, M. P., Kamps, M. P. (2006). Persistent Transactivation by Meis1 Replaces Hox Function in Myeloid Leukemogenesis Models: Evidence for Co-Occupancy of Meis1-Pbx and Hox-Pbx Complexes on Promoters of Leukemia-Associated Genes. Mol. Cell. Biol. 26: 3902-3916 [Abstract] [Full Text]  
  • Lin, Y.-W., Slape, C., Zhang, Z., Aplan, P. D. (2005). NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood 106: 287-295 [Abstract] [Full Text]  
  • Huang, H., Rastegar, M., Bodner, C., Goh, S.-L., Rambaldi, I., Featherstone, M. (2005). MEIS C Termini Harbor Transcriptional Activation Domains That Respond to Cell Signaling. J. Biol. Chem. 280: 10119-10127 [Abstract] [Full Text]  
  • Fischbach, N. A., Rozenfeld, S., Shen, W., Fong, S., Chrobak, D., Ginzinger, D., Kogan, S. C., Radhakrishnan, A., Le Beau, M. M., Largman, C., Lawrence, H. J. (2005). HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood 105: 1456-1466 [Abstract] [Full Text]  
  • Topisirovic, I., Kentsis, A., Perez, J. M., Guzman, M. L., Jordan, C. T., Borden, K. L. B. (2005). Eukaryotic Translation Initiation Factor 4E Activity Is Modulated by HOXA9 at Multiple Levels. Mol. Cell. Biol. 25: 1100-1112 [Abstract] [Full Text]  
  • Wermuth, P. J., Buchberg, A. M. (2005). Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood 105: 1222-1230 [Abstract] [Full Text]  
  • Iwasaki, M., Kuwata, T., Yamazaki, Y., Jenkins, N. A., Copeland, N. G., Osato, M., Ito, Y., Kroon, E., Sauvageau, G., Nakamura, T. (2005). Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood 105: 784-793 [Abstract] [Full Text]  
  • Beslu, N., Krosl, J., Laurin, M., Mayotte, N., Humphries, K. R., Sauvageau, G. (2004). Molecular interactions involved in HOXB4-induced activation of HSC self-renewal. Blood 104: 2307-2314 [Abstract] [Full Text]  
  • Kirito, K., Fox, N., Kaushansky, K. (2004). Thrombopoietin Induces HOXA9 Nuclear Transport in Immature Hematopoietic Cells: Potential Mechanism by Which the Hormone Favorably Affects Hematopoietic Stem Cells. Mol. Cell. Biol. 24: 6751-6762 [Abstract] [Full Text]  
  • Brun, A. C. M., Bjornsson, J. M., Magnusson, M., Larsson, N., Leveen, P., Ehinger, M., Nilsson, E., Karlsson, S. (2004). Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood 103: 4126-4133 [Abstract] [Full Text]  
  • Vijapurkar, U., Fischbach, N., Shen, W., Brandts, C., Stokoe, D., Lawrence, H. J., Largman, C. (2004). Protein Kinase C-Mediated Phosphorylation of the Leukemia-Associated HOXA9 Protein Impairs Its DNA Binding Ability and Induces Myeloid Differentiation. Mol. Cell. Biol. 24: 3827-3837 [Abstract] [Full Text]  
  • Kumar, A. R., Hudson, W. A., Chen, W., Nishiuchi, R., Yao, Q., Kersey, J. H. (2004). Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. Blood 103: 1823-1828 [Abstract] [Full Text]  
  • Deflorian, G., Tiso, N., Ferretti, E., Meyer, D., Blasi, F., Bortolussi, M., Argenton, F. (2004). Prep1.1 has essential genetic functions in hindbrain development and cranial neural crest cell differentiation. Development 131: 613-627 [Abstract] [Full Text]  
  • Rawat, V. P. S., Cusan, M., Deshpande, A., Hiddemann, W., Quintanilla-Martinez, L., Humphries, R. K., Bohlander, S. K., Feuring-Buske, M., Buske, C. (2004). Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 101: 817-822 [Abstract] [Full Text]  
  • Zeisig, B. B., Milne, T., Garcia-Cuellar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., Hess, J. L., Slany, R. K. (2004). Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization. Mol. Cell. Biol. 24: 617-628 [Abstract] [Full Text]  
  • LaRonde-LeBlanc, N. A., Wolberger, C. (2003). Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior. Genes Dev. 17: 2060-2072 [Abstract] [Full Text]  
  • Okada, Y., Nagai, R., Sato, T., Matsuura, E., Minami, T., Morita, I., Doi, T. (2003). Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene. Blood 101: 4748-4756 [Abstract] [Full Text]  
  • Pineault, N., Buske, C., Feuring-Buske, M., Abramovich, C., Rosten, P., Hogge, D. E., Aplan, P. D., Humphries, R. K. (2003). Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood 101: 4529-4538 [Abstract] [Full Text]  
  • Erkeland, S. J., Valkhof, M., Heijmans-Antonissen, C., Delwel, R., Valk, P. J. M., Hermans, M. H. A., Touw, I. P. (2003). The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood 101: 1111-1117 [Abstract] [Full Text]  
  • Mayotte, N., Roy, D.-C., Yao, J., Kroon, E., Sauvageau, G. (2002). Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system. Blood 100: 4177-4184 [Abstract] [Full Text]  
  • Buske, C., Feuring-Buske, M., Abramovich, C., Spiekermann, K., Eaves, C. J., Coulombel, L., Sauvageau, G., Hogge, D. E., Humphries, R. K. (2002). Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 100: 862-868 [Abstract] [Full Text]  
  • Fognani, C., Kilstrup-Nielsen, C., Berthelsen, J., Ferretti, E., Zappavigna, V., Blasi, F. (2002). Characterization of PREP2, a paralog of PREP1, which defines a novel sub-family of the MEINOX TALE homeodomain transcription factors. Nucleic Acids Res 30: 2043-2051 [Abstract] [Full Text]  
  • Bjornsson, J. M., Andersson, E., Lundstrom, P., Larsson, N., Xu, X., Repetowska, E., Humphries, R. K., Karlsson, S. (2001). Proliferation of primitive myeloid progenitors can be reversibly induced by HOXA10. Blood 98: 3301-3308 [Abstract] [Full Text]  
  • Calvo, K. R., Knoepfler, P. S., Sykes, D. B., Pasillas, M. P., Kamps, M. P. (2001). Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: Potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc. Natl. Acad. Sci. USA 10.1073/pnas.231115398v1 [Abstract] [Full Text]  
  • Calvo, K. R., Knoepfler, P. S., Sykes, D. B., Pasillas, M. P., Kamps, M. P. (2001). Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: Potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc. Natl. Acad. Sci. USA 98: 13120-13125 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»